Lipid signalling in disease
Top Cited Papers
- 1 February 2008
- journal article
- review article
- Published by Springer Nature in Nature Reviews Molecular Cell Biology
- Vol. 9 (2) , 162-176
- https://doi.org/10.1038/nrm2335
Abstract
Signalling lipids such as eicosanoids, phosphoinositides, sphingolipids and fatty acids control important cellular processes, including cell proliferation, apoptosis, metabolism and migration. Extracellular signals from cytokines, growth factors and nutrients control the activity of a key set of lipid-modifying enzymes: phospholipases, prostaglandin synthase, 5-lipoxygenase, phosphoinositide 3-kinase, sphingosine kinase and sphingomyelinase. These enzymes and their downstream targets constitute a complex lipid signalling network with multiple nodes of interaction and cross-regulation. Imbalances in this network contribute to the pathogenesis of human disease. Although the function of a particular signalling lipid is traditionally studied in isolation, this review attempts a more integrated overview of the key role of these signalling lipids in inflammation, cancer and metabolic disease, and discusses emerging strategies for therapeutic intervention.Keywords
This publication has 144 references indexed in Scilit:
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3KTrends in Immunology, 2007
- Inflammation and metabolic disordersNature, 2006
- A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell deathBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaCancer Cell, 2006
- Reactive oxygen species have a causal role in multiple forms of insulin resistanceNature, 2006
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004
- The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophagesNature Cell Biology, 2003